Award

NIHR Senior Investigator Award

Description: This Senior Investigator is the Director, Centre for Statistics in Medicine at Centre for Statistics in Medicine, they are in their 2nd term. Their primary research area is in Statistical Sciences and their secondary research specialty is in Internal Medicine.

Funder: National Institute for Health and Care Research

Amount:

Funding type: fellowship

Funder scheme: NIHR Senior Investigators

Start date: 2014-04-01

End date: 2017-03-31

Investigator: Douglas Altman

Institution: University of Oxford

Funded outputs count: 34

Funder award ID: NF-SI-0513-10131

OpenAlex ID: G2732516632

Choosing the target difference (‘effect size’) for a randomised controlled trial - DELTA2 guidance protocol

2017 · Jonathan A. Cook, Steven A. Julious, et al. · Trials · 14

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

2017 · Agnes Dechartres, Ludovic Trinquart, et al. · BMJ · 170

Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial

2016 · Sally Hopewell, Isabelle Boutron, et al. · BMC Medicine · 69

No rationale for 1 variable per 10 events criterion for binary logistic regression analysis

2016 · Maarten van Smeden, Joris A. H. de Groot, et al. · BMC Medical Research Methodology · 599

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges

2016 · Richard D Riley, Joie Ensor, et al. · BMJ · 583

Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited

2016 · Clément Lazarus, Romana Haneef, et al. · Journal of Clinical Epidemiology · 58

Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings

2016 · Rolf H.H. Groenwold, Karel G.M. Moons, et al. · Journal of Clinical Epidemiology · 73

Adequate sample size for developing prediction models is not simply related to events per variable

2016 · Emmanuel O. Ogundimu, Douglas G. Altman, et al. · Journal of Clinical Epidemiology · 543

Improving the relevance and consistency of outcomes in comparative effectiveness research

2016 · Sean R Tunis, Mike Clarke, et al. · Journal of Comparative Effectiveness Research · 95

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity

2016 · Amélie Yavchitz, Philippe Ravaud, et al. · Journal of Clinical Epidemiology · 221

Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey

2016 · Sarah L. Gorst, Elizabeth Gargon, et al. · PLoS ONE · 151

Sample size considerations for the external validation of a multivariable prognostic model: a resampling study

2015 · Gary S. Collins, Emmanuel O. Ogundimu, et al. · Statistics in Medicine · 662

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial

2015 · Caroline Barnes, Isabelle Boutron, et al. · BMC Medicine · 128

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)

2015 · Gary S. Collins, Johannes B. Reitsma, et al. · Annals of Internal Medicine · 492

Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences

2015 · Sally Hopewell, Isabelle Boutron, et al. · Journal of Clinical Epidemiology · 44

Avoidable waste of research related to inadequate methods in clinical trials

2015 · Y. Yordanov, A. Dechartres, et al. · BMJ · 152

New Guideline for the Reporting of Studies Developing, Validating, or Updating a Prediction Model

2015 · Karel G M Moons, Douglas G Altman, et al. · Clinical Chemistry · 3

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ( TRIPOD ): the TRIPOD statement

2015 · GS Collins, JB Reitsma, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 137

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement

2015 · G S Collins, J B Reitsma, et al. · British journal of surgery · 881

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ( TRIPOD ): the TRIPOD Statement

2015 · G. S. Collins, J. B. Reitsma, et al. · Diabetic Medicine · 20

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers

2015 · Jonathan A Cook, Jenni Hislop, et al. · Trials · 66

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement

2015 · Gary S. Collins, Johannes B. Reitsma, et al. · Journal of Clinical Epidemiology · 327

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

2015 · G. S. Collins, J. B. Reitsma, et al. · BMJ · 4,341

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

2015 · Karel G.M. Moons, Douglas G. Altman, et al. · Annals of Internal Medicine · 5,100

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement

2015 · Gary S. Collins, Johannes B. Reitsma, et al. · European Urology · 435